1 – 5 of 24
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
C3 glomerulopathy — understanding a rare complement-driven renal disease
2019) In Nature Reviews Nephrology(
- Contribution to journal › Scientific review
- 2017
-
Mark
Vitronectin Binds to a Specific Stretch within the Head Region of Yersinia Adhesin A and Thereby Modulates Yersinia enterocolitica Host Interaction
(
- Contribution to journal › Article
- 2016
-
Mark
Conserved Patterns of Microbial Immune Escape: Pathogenic Microbes of Diverse Origin Target the Human Terminal Complement Inhibitor Vitronectin via a Single Common Motif.
(
- Contribution to journal › Article
-
Mark
The complement inhibitor factor H generates an anti-inflammatory and tolerogenic state in monocyte-derived dendritic cells
(
- Contribution to journal › Article
- 2015
-
Mark
Pseudomonas aeruginosa Uses Dihydrolipoamide Dehydrogenase (Lpd) to Bind to the Human Terminal Pathway Regulators Vitronectin and Clusterin to Inhibit Terminal Pathway Complement Attack.
(
- Contribution to journal › Article